Physician profile
Davis Pappandreou Berry
NPI 1316380744
$1,299.88
in general payments reported to CMS, 2019-2025
26 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $98.42 · 2021: $30.31 · 2022: $208 · 2023: $222 · 2024: $364 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $208.56 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Atricure, INC. | $122.82 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Acera Surgical, INC. | $122.15 | 2024-2025 | Restrata Wound Matrix |
| Innovation Technologies INC | $116.32 | 2022-2025 | Irrisept |
| Integra Lifesciences Corporation | $108.00 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Convatec INC. | $57.70 | 2020-2024 | |
| Boston Scientific Corporation | $54.87 | 2022-2024 | Spyglass Discover |
| Ethicon US, LLC | $40.70 | 2023-2024 | Echelon; Endopath, Surgicel Nu-Knit, Evarrest |
| Tela Bio, INC. | $40.38 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Haemonetics Corporation | $37.85 | 2023 | Teg6s Hemostasis System |
| Ambu INC. | $36.44 | 2022 | |
| Avita Medical Americas, LLC | $33.77 | 2025 | Cohealyx, Permeaderm, Recell |
| Baxter Healthcare | $31.93 | 2023 | Floseal |
| Zimmer Biomet Holdings, INC. | $30.31 | 2021 | |
| Csl Behring | $28.45 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $28.41 | 2025 | Quikclot |
| Kowa Pharmaceuticals America, INC. | $24.92 | 2022 | |
| Cerus Corporation | $24.53 | 2023 | Intercept Blood System For Platelets |
| Solventum Corporation | $22.25 | 2025 | Prevena, Abthera Advance |
| Vertex Pharmaceuticals Incorporated | $21.50 | 2025 | |
| Abbott Laboratories | $20.36 | 2024 | I-Stat |
| Janssen Pharmaceuticals, INC | $19.98 | 2020 | |
| Pfizer INC. | $19.72 | 2020 | |
| La Jolla Pharmaceutical Company | $18.08 | 2025 | Giapreza |
| Aroa Biosurgery Incorporated | $18.01 | 2025 | |
| Kls-Martin L.P. | $11.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davis Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.